Ahmed S. Alnatsha

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Journal: Gut

Published: October 23, 2025

deltaHED predicts survival and immune evasion in PD-1 blockade therapy: A multi-cohort study across three cancer types.

deltaHED predicts survival and immune evasion in PD-1 blockade therapy: A multi-cohort study across three cancer types.

Journal: Clinical and translational medicine

Published: September 16, 2025

Breast cancer awareness and breast self-examination among females in the Middle East and North Africa: a multinational cross-sectional study.

Breast cancer awareness and breast self-examination among females in the Middle East and North Africa: a multinational cross-sectional study.

Journal: BMJ oncology

Published: May 20, 2025

LDAcoop: Integrating non-linear population dynamics into the analysis of clonogenic growth in vitro.

LDAcoop: Integrating non-linear population dynamics into the analysis of clonogenic growth in vitro.

Journal: Molecular oncology

Published: April 17, 2025

Diagnostic accuracy and Patient Derived Organoid (PDO) yield of 19G vs 22G Franseen needles for EUS-Guided biopsy in solid pancreatic lesions: A prospective comparative study.

Diagnostic accuracy and Patient Derived Organoid (PDO) yield of 19G vs 22G Franseen needles for EUS-Guided biopsy in solid pancreatic lesions: A prospective comparative study.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: January 22, 2025

Knowledge and attitudes toward cancer clinical trials: a multi-national cross-sectional study in the Middle East and North Africa.

Knowledge and attitudes toward cancer clinical trials: a multi-national cross-sectional study in the Middle East and North Africa.

Journal: BMC cancer

Published: December 30, 2024

TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status.

TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status.

Journal: Cancers

Published: August 02, 2022

Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis.

Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis.

Journal: Gastroenterology

Published: February 01, 2022

CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver.

CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver.

Journal: Nature protocols

Published: July 28, 2021

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma.

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma.

Journal: Cells

Published: June 08, 2021

Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.

Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.

Journal: Gastroenterology

Published: September 21, 2020

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.

Journal: Pharmacogenetics and genomics

Published: September 21, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026